As part of the SGLT2 HYPE project, patients were actively involved in the co-creation process of our Home Blood Pressure App. Interviews with three of the 20 participating patients provide valuable insights into why it is so important to include the opinions and perspectives of those affected from the very beginning.
The patients also reflect on their experiences of participating in such a co-creation process and supporting the development of targeted outputs within a clinical trial. Importantly, they encourage other patients to become actively involved in similar initiatives in the future.
While scientific motivation and rationale are indispensable, research can only achieve real-world impact if the perspectives and needs of the actual end users are taken into account. Patient involvement is essential to ensure acceptance, usability, and meaningful added value in everyday care.
A heartfelt thank you to all patients for their valuable contributions and openness, and to our project partner Deutsche Herzstiftung (DHS), represented by Christine Dehn, for conducting these insightful interviews, the project Partner Medizinische Universität Innsbruck, represented by Prof. Sebastain Reinstadler and Dr. Ivan Lechner, our App developer Agindo, represented by Oliver Zott, as well as all the other contributors.
